Percutaneous transluminal coronary angioplasty or coronary artery bypass grafting for coronary artery disease?

Scandinavian Cardiovascular Journal

Volumn 31, Issue 4, 1997, Pages 201-211

  Währborg, Peter ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angioplasty; Bypass; Coronary disease

Indexed keywords

ANGINA PECTORIS; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DIABETES MELLITUS; GRAFT OCCLUSION; GRAFT PATENCY; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVASCULARIZATION; REVIEW; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 1842409529     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.3109/14017439709041747     Document Type: Review

References (104)

1. Adebo OA, Lee CN, Mestres CA. Myocardial revascularisation in patients with carotid artery disease. Ann Acad Med Singapore 1991; 20: 228-230.
2. Atkinsson JB, Forman MB, Vaughn WK. Morphologic changes in long-term saphenous vein grafts. Chest 1985; 88: 341-348.
3. BARI Investigators. Protocol for the bypass angioplasty revascularisation investigation. Circulation 1991; 84 Suppl V: 1-27.
4. Beck CS. Principles underlying the operative approach to the treatment of myocardial ischemia. Ann Surg 1943; 118: 788-806.
5. Beck CS. Revascularization of the heart. Ann Surg 1948; 128: 854-864.
6. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987; 257: 3233-3240.
7. Bourassa MG, Enjalbert M, Campeau L. Progression of atherosclerosis in coronary arteries and bypass grafts. Ten year later. Am J Cardiol 1984; 53: 102C-107C.
8. Bourassa MG, Campeau L, Lesperance J. Changes in grafts and in coronary arteries after coronary bypass surgery. Cardiovasc Clin 1991; 21: 83-100.
9. Bourassa MG. Results of the Bypass Angioplasty Revascularization Investigation. Second CABRI Investigators Meeting, Liege, 11 October, 1996..
10. Brandrup-Wognsen G. Coronary artery bypass grafting. Mortality and morbidity during two years of follow-up. Thesis. Department of Cardiothoracic Surgery, Göteborg University, Sahlgrenska University Hospital, Göteborg, Sweden, 1995.
11. Brandrup-Wognsen G, Haglid M, Karlsson T, Berggren H, Herlitz J. Preoperative risk indicators of death at an early and late stage after coronary artery bypass grafting. Thorac Cardiovasc Surg 1995; 43: 77-82.
12. CABRI Trial Participants. First year results of CABRI (Coronary Angioplasty vs Bypass Revascularisation Investigation. Lancet 1995; 346: 1179-1184.
13. Campeau L. Grading of angina pectoris. Circulation 1976; 54: 522-523.
14. Campeau L, Enjalbert M, Lesperance J, Vaislick C, Grondin CM, Bourassa MG. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: Sequential angiographic studies at 2 weeks, 1 year, 5 to 7 tears, and 10 to 12 years after surgery. Circulation 1983; 68 Suppl II: 1-9.
15. Campeau L, Enjalbert M, Lesperance J, et al. The relation of risk factors to the development of atherosclerosis in saphenous-vein grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med 1984; 311: 1329-1332.
16. Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn DH. Beneficial effects of colestipol-niacin on coronary atherosclerosis. J Am Med Assoc 1990; 264: 3013-3017.
17. CASS Principal Investigators and their associates. Coronary Artery Surgery Study (CASS): a randomised trial of coronary artery bypass surgery: survival data. Circulation 1983; 68: 939-950.
18. Chesebro JH, Clements IP, Fuster V, et al. A platelet-inhibitor-drug trial in coronary artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med 1982; 307: 73-78.
19. Chaitman BR, Alderman EL, Sheffield LT. Use of survival analysis to determine the clinical significance of new Q-waves after coronary bypass surgery. Circulation 1983; 67: 302.
20. Cournand AF Nobel lecture, 11 December, 1956. In: Nobel lectures, physiology and medicine 1942-1962. Amsterdam: Elsevier, 1964: 529.
21. Cowley MJ, Vetrovec GW, Disciascio G, Lewis SA, Hirsch PD, Wolfgang TC. Coronary angioplasty of multiple vessels: short term outcome and long-term results. Circulation 1985; 72: 1314-1320.
22. Cragg A, Amplatz K. Vascular pathophysiology of transluminal angioplasty. In: Jang GD, ed. Angioplasty. New York: McGraw-Hill, 1986: 145-155.
23. De Feyter PJ, van den Brand M, Laarman GJ, et al. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Frequency, prediction, clinical course, management and follow-up. Circulation 1991; 83: 927-936.
24. Deligonul U, Vandormael MG, Kern MJ, Zelman R, Galan K, Chaitman BR. Coronary angioplasty: a therapeutic option for symptomatic patients with two and three vessel coronary disease. J Am Coll Cardiol 1988; 11: 1173-1179.
25. Detre KM, Holmes Jr DR, Holubkov R, et al. Incidence and consequences of periprocedural occlusion. The 1985-1986 National Heart, Lung and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1990; 82: 739-750.
26. Donahue RP, Orchard TJ. Diabetes mellitus and macro vascular complications. An epidemiological perspective. Diabetes Care 1992; 15: 1141-1155.
27. Drexel H, Amann FW. Lipids and lipid-lowering drugs and graft function. In: Lüscher TF, Turina M, Braunwald E, eds. Coronary artery graft disease. Berlin: Springer Verlag, 1994.
28. European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982; 2: 1173-1180.
29. Faggioli GL, Curl GR, Ricotta JJ. The role of carotid screening before coronary artery bypass. J Vasc Surg 1990; 12: 724-729.
30. Favaloro RG, Effler et al. Saphenous vein graft in the surgical treatment of coronary artery disease: operative technique. J Thorac Cardiovasc Surg 1969; 58: 178-185.
31. Fischman DL, Leon MB, Baim DS, et al. A randomised comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501.
32. FitzGibbon GM, Leach AJ, Kafka HP. Atherosclerosis of coronary artery by pass grafts and smoking. Can Med Assoc J 1987; 136: 45-47.
33. Fox MH, Gruchow HW, Barboriak JJ, et al. Risk factors among patients undergoing repeated aorta-coronary by pass procedures. J Thorac Cardiovasc Surg 1987; 93: 56-61.
34. Frye RL, Kronmal R, Schaff HV, Myers WO, Gersh BJ. Stroke in coronary artery bypass surgery: an analysis of the CASS experience. The participants in the Coronary Artery Surgery Study. Int J Cardiol 1992; 36: 212-221.
35. Goy JJ, Eeckhout E, Burnand B, et al. Coronary angioplasty versus left internal mammary artery grafting for isolated proximal left anterior descending artery stenosis. Lancet 1994; 343: 1449-1453.
36. Grondin CM, Campeau L, Thornton JC, Engle JC, Cross FS, Schreiber H. Coronary artery bypass grafting with saphenous vein. Circulation 1989; 79 Suppl I: 24-29.
37. Grüentzig A. Transluminal dilation of coronary-artery stenosis. Lancet 1978; 1: 263.
38. Gruentzig AR, Senning A, Siegenthaler WE. Non-operative dilation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301: 61-68.
39. Gruentzig AR, King III SB, Schlumpf M, Siegenthaler WE. Long-term follow-up after percutaneous transluminal coronary angioplasty: the early Zurich experience. N Engl J Med 1987; 316: 1127-32.
40. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. The German Angioplasty Bypass Surgery Investigation: a randomised study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med 1994; 331: 1037-1043.
41. Hammeke TA, Hastings JE. Neuropsychological alterations after cardiac operation. J Thorac Cardiovasc Surg 1988; 96: 326-331.
42. Hartz AJ, Kuhn EM, Pryor DB, et al. Mortality after coronary angioplasty and coronary artery bypass surgery (the national Medicare experience). Am J Cardiol 1992; 70: 179-185.
43. Hollman J, Austin GE, Gruentzig AR. Coronary artery spasm at the site of angioplasty in the first 2 months after successful PTCA. J Am Coll Cardiol 1983; 2: 1039-45.
44. Holmes Jr DR, Vlietstra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984; 53: 77C-81C.
45. Hueb W, Bellotti G, de Oliveira SA, et al. The Medicine, Angioplasty or Surgery Study (MASS): a prospective randomised trial for single proximal left anterior descending artery stenosis. J Am Coll Cardiol 1995; 26: 1600-1605.
46. Ilsley C. Interim report of 2-5 years follow-up on patients in the CABRI trial. Second CABRI Investigators Meeting, Liege, 11 October, 1996..
47. Jang IK, Fuster V. Mechanisms of plaque formation and occlusion in venous coronary bypass grafts. In: Lüscher TF, Turina M, Braunwald E, eds. Coronary artery graft disease. Berlin: Springer Verlag, 1994.
48. Johansson SR, Brorsson B, Bernstein SJ. Coronary artery bypass graft and percutaneous transluminal coronary angioplasty. A literature review and ratings of appropriateness and necessity. The Swedish Council on Technology Assessment in Health Case Report no 120E, 1994.
49. Jones RH, Kesler K, Phillips III HR, et al. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg 1996; 111: 1013-1025.
50. Jonnesco TH. Angine de poitrine guérie pat la résection du sympathique cervicothoracique. Bull Acad Méd 1920; 84: 93-102.
51. Juolasmaa A, Outakoski J, Hirvenoja R, Tienari P, Sotaniemi K, Takkunen J. Effect of open-heart surgery on intellectual performance. J Clin Neuropsychol 1981; 3: 181-197.
52. Khoury M, Batra S, Berg R, Rama K, Kozul V. Influence of arterial access sites and interventional procedures on vascular complications after cardiac catheterization. Am J Surg 1992; 164: 205-209.
53. King III SB, Schlumpf M. Ten-year completed follow-up of percutaneous transluminal coronary angioplasty: the early Zurich experience. J Am Coll Cardiol 1993; 22: 353-360.
54. King III SB, Lembo NJ, Weintraub WS, et al. The Emory Angioplasty versus Surgery Trial (EAST): A randomised trial comparing coronary angioplasty with coronary bypass surgery. N Engl J Med 1994; 331: 1044-50.
55. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey SF, Currier JW, for the Investigators of the NHLBI PTCA Registry. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 1996; 94: 1818-1825.
56. Kirklin JW, Naftel DC, Blackstone EH, Pohost GM. Summary of a consensus concerning death and ischemic events after coronary artery bypass grafting. Circulation 1989; 79 Suppl I: 81.
57. Kleinman JC, Donahue RP, Harris MI, Finucane FF, Madans HJ, Brock DB. Mortality among diabetics in a national sample. Am J Epidemiol 1988; 128: 389-340.
58. Kuroda Y, Uchimoto R, Kaieda R, et al. Central nervous system complications after cardiac surgery: a comparison between coronary artery bypass grafting and valve surgery. Anesth Analg (Paris) 1993; 76: 222-227.
59. Lie JT, Lawrie GM, Morris GC. Aortocoronary bypass saphenous vein graft atherosclerosis. Am J Cardiol 1977; 40: 906-914.
60. Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty: potential biologic determinants and role of intimal hyperplasia. Circulation 1989; 79: 1374-1387.
61. Lynn GM, Stefanko K, Reed III JF, Gee W, Nicholas G. Risk factors for stroke after coronary artery bypass. J Thorac Cardiovasc Surg 1992; 104: 1518-1523.
62. Mabin TA, Holmes DR, Smith HC. Intracoronary thrombus: role in coronary occlusion complicating percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985; 5: 198-202.
63. Mabin TA, Holmes DR, Smith HC, et al. Follow up clinical results in patients undergoing percutaneous transluminal coronary angioplasty. Circulation 1985; 71: 754-760.
64. Magovern JA, Mack MJ, Landreneau RJ, et al. The minimally invasive approach reduces the morbidity of coronary artery bypass. Circul Abstr 1996; 94 Suppl I: I-52.
65. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease. Circulation 1994; 89: 2015-2025.
66. Mata LA, Bosch X, David PR, Rapold HJ, Corcos T, Bourassa MG. Clinical and angiographic assessment 6 months after double vessel percutaneous coronary angioplasty. J Am Coll Cardiol 1985; 6: 1239-1244.
67. Meyer BJ, Meier B, Bonzel J, et al. Working group on Coronary Circulation of the European Society of Cardiology: Interventional cardiology in Europe 1993. Eur Heart J 1996; 17: 1318-1328.
68. Myler RK, Topol EJ, Show RE, et al. Multiple vessel coronary angioplasty: classification results and patterns of restenosis in 494 consecutive patients. Cathet Cardiovasc Diagn 1987; 13: 1-15.
69. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol 1988; 12: 616-623.
70. O'Keefe Jr JH, Rutherford BD, McConahay DR, et al. Multivessel coronary angioplasty from 1980 to 1989; procedural results and long-term outcome. J Am Coll Cardiol 1990; 16: 1097-1102.
71. Pfisterer M. Anticoagulants and antiplatelet drugs to prevent aortocoronary vein graft occlusion. In: Lüscher TF, Turina M, Braunwald E, eds. Coronary artery graft disease. Berlin: Springer Verlag, 1994.
72. Pocock SJ, Hendersson RA, Rickards AF, et al. Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet 1995; 346: 1184-1189.
73. Pocock SJ, Henderson RA, Seed P, Treasure T, Hampton JR, for the RITA Trial Participants. Quality of life, employment status, and anginal symptoms after coronary angioplasty or bypass surgery. Circulation 1996; 94: 135-142.
74. Proudfit WL, Kramer JR, Goormastic M, Loop FD. Survival of patients with mild angina or myocardial infarction without angina: a comparison of medical and surgical treatment. Br Heart J 1988; 59: 641.
75. Puel J, Karouny E, Marco F. Angioplasty versus surgery in multivessel disease: immediate results and in-hospital outcome in a randomised prospective study. Circulation 1992; 86 Suppl I: 372.
76. Reitz BA, Stevens JH, Burdon TA, St. Goar FG, Siegel LC, Pompili MF. Post-access coronary artery bypass grafting: lessons learned in a Phase I clinical trial. Circul Abstr 1996; 94 Suppl I: I-52.
77. Rensing BJ, Hermans WRM, Beatt KJ. Quantitative angiographic assessment of elastic recoil after percutaneous coronary angioplasty. Am J Cardiol 1990; 66: 1039-1044.
78. Rihal CS, Yusuf S. Chronic coronary artery disease: drugs, angioplasty or surgery. Br Med J 1996; 312: 265-266.
79. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial. Lancet 1993; 343: 573-580.
80. Rodriguez A, Boullon F, Perez-Balino N, Paviotti C, Liprandi MS, Palacios IF, on behalf of the ERACI Group. Argentine randomised trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow up. J Am Coll Cardiol 1993; 22: 1060-1067.
81. Rossiter SJ, Brody WR, Kosek JC, Liptom MJ, Angell WW. Internal mammary artery versus autogenous vein for coronary artery bypass graft. Circulation 1974; 50: 1236-1243.
82. Sabiston Jr DC. Direct surgical management of congenital and acquired lesions of the coronary circulation. Prog Cardiovasc Dis 1963; 6: 299.
83. Sabiston Jr DC. The coronary circulation. Hopkins Med J 1974; 134: 314-329.
84. Sanz G, Pajarón A, Alegría E, et al. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Circulation 1990; 82: 765-773.
85. Scott Jr HW, Morgan CW, Bolasny BL, Lainer VC, Younger RK, Butts W. Experimental atherosclerosis in autogenous venous grafts. Arch Surg 1970; 101: 677-682.
86. Serruys PW, Jaegere PD, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495.
87. Shaw P. The intellectual function of patients after coronary bypass surgery. In Walter PJ, ed. Quality of life after open heart surgery. Dordrecht: Kluwer Academic Publishers, 1992.
88. Schwartz RS, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 19: 267-274.
89. Sigwart U, Puel J, Mirkovitch V, Joffr F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med 1987; 316: 701-706.
90. Smith LR, Harrell Jr FE, Rankin JS, et al. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation 1991; 84 Suppl I: III-245-253.
91. Sones FM, Shirey EK. Cine coronary arteriography. Mod Concepts Cardiovasc Dis 1962; 31: 735-738.
92. Sones FM, Shirey EK, Proudfit WL, Westcott RN. Cine coronary arteriography. Circulation 1959; 20: 773.
93. Sotaniemi KA, Juolasmaa A, Hokkanen ET. Neuropsychologic outcome after open heart surgery. Arch Neurol 1981; 38: 2-8.
94. Tschan W, Hoffman A, Burkart F, et al. Coronary by pass grafts. Influence of preoperative risk factors on the late postoperative course. Chest 1985; 88: 185-189.
95. Vacek JL, Rosamond TL, Stites HW, et al. Comparison of percutaneous transluminal coronary angioplasty versus coronary artery bypass grafting for multivessel coronary artery disease. Am J Cardiol 1992; 69: 592-597.
96. Vandormael WS, King III SB, Jones EL, et al. Multilesion coronary angioplasty: clinical and angiographic follow-up. J Am Coll Cardiol 1987; 10: 246-252.
97. Varnauskas E, the European Coronary Surgery Study Group. Twelve year follow-up of survival in the randomised European Coronary Surgery Study. N Engl J Med 1988; 319: 332-337.
98. Veterans Administration Coronary Artery Bypass Surgery Co-operative Study Group. Eleven-year survival in the Veterans Administration randomised trial of coronary bypass surgery for stable angina. N Engl J Med 1984; 311: 1333-1339.
99. Veterans Administration VA Coronary Artery Bypass Surgery Co-operative Study Group. Eighteen-year follow-up in the Veterans Administration co-operative study of coronary artery bypass surgery for stable angina. Circulation 1992; 86: 121-130.
100. Vlodaver Z, Edwards JE. Pathologic changes in aortic-coronary arterial saphenous vein graft atherosclerosis. Circulation 1971; 44: 719.
101. Weintraub WS, Jones EL, King III SB, et al. Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease. Am J Cardiol 1990; 65: 183-188.
102. Weintraub WS, King III SB, Jones EL, et al. Coronary surgery and coronary angioplasty in patients with two-vessel coronary artery disease. Am J Cardiol 1993; 71: 511-517.
103. Wilentz J, Sanborn T, Haudenschild C, Vireri C, Repan T, Faxon D. Platelet accumulation in experimental angioplasty: time course in relation to vascular injury. Circulation 1987; 75: 636.
104. Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-years results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 1994; 344: 563-570.